!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Research

Advanced Liver Therapies Research

Master
Heading

ALT Studies

Content

Advanced Liver Therapies provides studies/clinical trials for a variety of liver diseases, including:

  • Hepatitis C
  • Hepatitis B
  • Fatty liver disease
  • Hepatic encephalopathy
  • Primary biliary cirrhosis
  • Hepatorenal syndrome
  • Anti-fibrosis
  • Cirrhosis

 

View Clinical Trials
Heading

Services

Content

As an important initiative of the Office of Clinical Research efforts, the ALT:

  • Collaborates with scientists to establish translational research
  • Advocates to encourage the pharmaceutical industry to develop new tests and therapies
  • Provides advisors for new research protocol designs
  • Publishes research results in peer-reviewed publications
Media Component
Media
Heading

What Is Non-Alcoholic Fatty Liver Disease?

Heading

Physician Outreach

Content

Do you have patients living with liver disease? See research studies/clinical trials currently enrolling participants and refer your patients to enroll. 

View Studies Listings
Heading

Dr. John M. Vierling Joins IQ-DILI Initiative

Content

John M. Vierling, M.D., professor of medicine and surgery at Baylor College of Medicine and director of Advanced Liver Therapies at Baylor St. Luke’s Medical Center, was invited to contribute to the IQ Consortium Drug Induced Liver Initiative (IQ-DILI).

Back to topback-to-top